HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
Authors
Keywords
-
Journal
Scientific Reports
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-12-11
DOI
10.1038/srep03470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells
- (2013) Sun-Mi Yun et al. CANCER LETTERS
- Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells
- (2013) Ting Bai et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis
- (2012) Hyunseung Lee et al. CANCER LETTERS
- Lipopolysaccharide Induces Lung Fibroblast Proliferation through Toll-Like Receptor 4 Signaling and the Phosphoinositide3-Kinase-Akt Pathway
- (2012) Zhengyu He et al. PLoS One
- Targeting phospshatidylinositol 3-kinase signaling with novel phosphatidylinositol 3,4,5-triphosphate antagonists
- (2011) Benchun Miao et al. Autophagy
- Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches
- (2011) Elisabetta Mormone et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms
- (2011) Enrico Conte et al. PLoS One
- Current status of novel antifibrotic therapies in patients with chronic liver disease
- (2011) Michal Cohen-Naftaly et al. Therapeutic Advances in Gastroenterology
- The use of low molecular weight heparin–pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway
- (2010) Ju-Hee Lee et al. BIOMATERIALS
- New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
- (2010) Yan Wang et al. JOURNAL OF HEPATOLOGY
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
- (2009) H Christian Reinhardt et al. CURRENT OPINION IN CELL BIOLOGY
- Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis
- (2009) Gakuhei Son et al. HEPATOLOGY
- Differential phosphorylation of Cdc25C phosphatase in mitosis
- (2008) Jérôme Bonnet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search